Facial Blushing: Patient Selection and Long-Term Results.
Facial blushing, associated with social phobia, may have severe negative impact on the quality of daily life. The first line of treatment should be psychological and/or pharmacologic. In severe cases not responding to nonsurgical treatment, surgical sympathetic denervation is an option. A thorough disclosure of effects, complications, and side effects is mandatory and patient selection is crucial to obtain high patient satisfaction from surgical treatment.
Department of Vascular Surgery, Sahlgrenska University Hospital, Per Dubbsgatan 1, Gothenburg S-41345, Sweden.
Smidfelt
S
Kristian
Borås Hospital, Brämhultsvägen 53, Borås S-50182, Sweden; Sahlgrenska University, Gothenburg, Sweden. Electronic address: christer.drott@vgregion.se.
Drott
D
Christer
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001821:Blushing / Q000502:physiology / Q000523:psychology; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy; D006801:Humans; D017060:Patient Satisfaction; D018579:Patient Selection; D000072861:Phobia, Social / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013562:Sympathectomy; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D017367:Selective Serotonin Reuptake Inhibitors
ETS; Facial blushing; Social phobia; Sympathectomy